Australia Stock Exchange release from PYC THERAPEUTICS : Completes FDA Pre-IND engagement - RP11 program
23/03/2022 24:00
Australia Stock Exchange release from PYC THERAPEUTICS PYC.AX : Completes FDA Pre-IND engagement - RP11 program
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director